Atlas Trials

Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)

Clinical trial NCT01124253 · COMPLETED

Trial details

NCT number
NCT01124253
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2007-07-01
Primary completion
2009-10-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.